Goodyear Tire & Rubber Co vs Heron Therapeutics Inc — how do they compare? Goodyear Tire & Rubber Co trades at $6.12 (market cap $1.75B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: Goodyear Tire & Rubber Co is far larger — about 28.5× Heron Therapeutics Inc's market cap, and Goodyear Tire & Rubber Co is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| GT | HRTX | |
|---|---|---|
Market Cap | $1.75B | $61.47M |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $1.49 |
52-Week Low | $5.58 | $0.32 |
Enterprise Value | $9.11B | $168.21M |
Signals from Pluang's Aura AI — not financial advice
Goodyear Tire & Rubber (GT) trades at $6.03, down 6.37% over 24 hours, reflecting bearish technical signals and weak fundamentals. The stock shows negative profitability with a net income margin of -14.37% and ROE of -63.93% as of 2025, while recent Q2 2026 earnings missed on EPS but beat revenue estimates. Cash flow improved to a net $46 million in 2025, yet debt levels remain elevated with a debt-to-asset ratio of 34.36%.
Outlook remains challenging due to volume pressures and high costs, though analyst consensus leans hold (50%) with some buy support (34.62%). Key risks include sustained losses, competitive pressures, and macroeconomic headwinds impacting tire demand, requiring careful monitoring of turnaround efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →